NCT00372398

Brief Summary

The purpose of this trial is to study the proportion of scleroderma patients who suffer from asymptomatic coronary atherosclerosis compared to healthy controls.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2006

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 5, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 6, 2006

Completed
25 days until next milestone

Study Start

First participant enrolled

October 1, 2006

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2010

Completed
Last Updated

September 16, 2010

Status Verified

September 1, 2010

Enrollment Period

3.8 years

First QC Date

September 5, 2006

Last Update Submit

September 15, 2010

Conditions

Keywords

sclerodermasclerosisatherosclerosis

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

scleroderma patients

You may qualify if:

  • Age \>= 18 years.
  • Fulfillment of the American College of Rheumatology (ACR) criteria for the classification of scleroderma.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tuen Mun Hospital

Hong Kong, Hong Kong

Location

MeSH Terms

Conditions

Scleroderma, DiffuseSclerosisAtherosclerosis

Condition Hierarchy (Ancestors)

Scleroderma, SystemicConnective Tissue DiseasesSkin and Connective Tissue DiseasesSkin DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • CC Mok, MD FRCP

    Tuen Mun Hospital Hong Kong

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER GOV

Study Record Dates

First Submitted

September 5, 2006

First Posted

September 6, 2006

Study Start

October 1, 2006

Primary Completion

July 1, 2010

Study Completion

July 1, 2010

Last Updated

September 16, 2010

Record last verified: 2010-09

Locations